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INTRODUCTION
 ■ In 2011, the U.S. Government Accountability Office (GAO) reported rates 
of psychotropic prescriptions for foster and non-foster children in Medicaid 
fee-for service in five states.
 – Massachusetts exhibited the highest rate of behavioral health 
medication (BHM) utilization with 49.3% of all Medicaid children being 
prescribed a psychotropic medication, and 39.1% of children in foster 
care prescribed these medications.1
 ■ In 2012, the U.S. GAO reported a higher prevalence of BHM regimens 
with ≥5 medications in foster care children. Antipsychotic use in children 
covered by Medicaid was twice as likely compared to those privately 
insured.2
 ■ The Massachusetts Medicaid (MassHealth) Pharmacy Program, in 
collaboration with the Department of Children and Families and the 
Department of Mental Health implemented the PBHMI in November 2014.
 – Proactively requires prior authorization (PA) for specific medications or 
combinations of BHMs prescribed to members less than 18 years of age.
 ■ A multidisciplinary therapeutic class management (TCM) workgroup 
consisting of child/adolescent psychiatrists, pharmacists, and a social 
worker, retrospectively reviews complex cases.
 – Interventions include telephonic prescriber outreach by a child/
adolescent psychiatrist to discuss opportunities for regimen 
simplification, drug interactions or toxicity, and to encourage  
evidence-based practices.
OBJECTIVES
 ■ Primary Objective: To determine the impact of the PBHMI telephonic 
peer-to-peer outreach program in modifying prescribing trends by 
assessing the rate of acceptance, modified acceptance, or rejection of 
medication interventions suggested by the workgroup.
 ■ Secondary Objectives: To assess the impact of prescriber type and 
medication class on peer-to-peer outreach outcomes. In addition, to 
assess prescriber satisfaction with the peer-to-peer outreach process.
METHODS
 ■ Population Selection
 – MassHealth members identified as candidates for a peer-to-peer 
outreach call based upon PBHMI TCM workgroup review during the 
time period of September 1, 2015 through August 28, 2016 who had 
continuous coverage throughout the TCM review and no third party 
liability (TPL).
 ■ Primary Outcome
 – Case data was utilized to collect the types of interventions, number 
of peer-to-peer consultations conducted, and suggested medication 
recommendations.
 – Pharmacy claims and subsequent PA submissions were analyzed to 
assess medication regimens prior to workgroup intervention, as well as 
changes to the medication regimen after the peer-to peer-discussion.
 – Peer-to-peer recommendations were categorized as:
 › Acceptance of a recommendation: Change to a regimen discussed 
during the peer-to-peer
 › Modified acceptance: When ≥1 recommendation was implemented 
or a prescriber implemented a change that was revised from the 
original recommendation
 › Rejection: A prescriber did not modify the regimen discussed
 ■ Secondary Outcomes
 – The rate of acceptance was assessed based upon type of prescriber 
and the medication class being recommended.
 – An anonymous and voluntary survey was faxed to prescribers who 
participated in a peer-to-peer to assess prescriber satisfaction.
DISCUSSION
 ■ Peer-to-peer outreach calls conducted by the TCM workgroup resulted 
in a medication regimen recommendation acceptance rate of 31.4%, 
modified acceptance rate of 44.3%, and rejection rate of 24.3%.
 ■ Recommendations made during a peer-to-peer were more likely to be 
accepted or modified by a non-child/adolescent psychiatrist than a child/
adolescent psychiatrist. Recommendations were more likely to be rejected 
by a child/adolescent psychiatrist than a non-child/adolescent psychiatrist 
(Figure 2; P=0.4106).
 ■ Antipsychotics were recommended for change most frequently during a 
peer-to-peer, accounting for 26.8% of recommendations.
 ■ Recommended changes for regimens containing a benzodiazepine had 
the highest likelihood of prescriber acceptance. 
 – All recommendations (N=9) were accepted (P=0.0758). 
LIMITATIONS
 ■ Changes to member regimens may not be fully reflected by data collected 
from pharmacy claims or PA submissions.
 ■ Cases where a peer-to-peer consultation occurred earlier in the study period 
may have allowed for more interventions to take place, as opposed to peer-
to-peers completed towards the end of the study period.
 ■ The PBHMI TCM workgroup routinely reviews cases for members with 
TPL; however, a lack of access to pharmacy claims data for these members 
prevents their inclusion in this analysis and therefore, maybe not represent 
the true impact of the program.
 ■ The sample size during the study period was not large enough to exhibit  
statistical significance between subgroups.
 ■ Acceptance of recommendations may have been limited by additional factors 
including a member changing providers, care settings, or a decline in mental 
health status.
 ■ This is an interim analysis and results for the prescriber survey are pending.
CONCLUSION
 ■ The results of this analysis suggest a peer-to-peer outreach program is 
associated with increased awareness and implementation of evidence-
based medicine in a pediatric population treated with behavioral health 
medications.
 ■ The type of prescriber and medication class being recommended for 
change may have an impact on the likelihood of recommendation 
acceptance.
 ■ Full results anticipated in May 2017.
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FIGURE 1: Rate of Acceptance of Medication Regimen Recommendations
FIGURE 2: Comparison of Prescriber Type on Acceptance, Modified Acceptance and 
Rejection of Medication Regimen Recommendations
FIGURE 3: Total Peer-to-Peer 
Recommendations by Drug Class
FIGURE 4: Accepted and Modified  
Peer-to-Peer Recommendations by Drug Class
FIGURE 5: Rejected Peer-to-Peer 
Recommendations by Drug Class
TABLE 1: Survey Questions Assessing Prescriber Satisfaction with the PBHMI TCM Peer-to-Peer Process
Did you find the peer-to-peer with a PBHMI TCM child/adolescent psychiatrist helpful?                ❒ YES       ❒ NO
How satisfied were you with the scheduling process? ❒ 1           ❒ 2           ❒ 3           ❒ 4          ❒ 5
Did the intervention(s) suggested during the peer-to-peer change your approach to 
managing the individual patient?
❒ YES       ❒ NO
Did the intervention(s) suggested during the peer-to-peer change your overall approach 
to managing all patients within your practice?
❒ YES       ❒ NO
How valuable did you find the amount of time required to participate in the peer-to-peer? ❒ 1           ❒ 2           ❒ 3           ❒ 4          ❒ 5
Did the peer-to-peer increase your understanding of additional available resources for 
patient care?
❒ YES       ❒ NO
Overall, how satisfied were you with the PBHMI TCM workgroup peer-to-peer process? ❒ 1           ❒ 2           ❒ 3           ❒ 4          ❒ 5
© 2017 University of Massachusetts Medical School
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*Non-child/adolescent psychiatrists include: nurse practitioners, neurologists, pediatricians, general or adult psychiatrists.
Alpha-2 agonist Antidepressant Antipsychotic Benzodiazepine Mood stabilizer Stimulant Other BHM* Non-BHM*
*Other BHMs include atomoxetine, buspirone, benztropine, cyproheptadine, and amantadine. Non-BHMs include metformin.
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